三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
RC48在UC患者中最佳总缓解情况
RC48在UC患者中最佳总缓解情况
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:1403KB
图片尺寸:2268*1559
同报告图片
/
4
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
fCDkvZznlKjmnLrliLYgfCDoja/lk4HlkI3np7AgfCDnoJTlj5HmnLrmnoQgfCDpnbbngrkgfCBJ5pyfIHwgSUnmnJ8gfCBJSUnmnJ8gfCDojrfmibnkuIrluIIgfAp8LS0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS18LS0tLS18LS0tLS0tfC0tLS0tLS18LS0tLS0tLS18Cnwg57u06L+q6KW/5aal5Y2V5oqXIHwg6I2j5piM55Sf54mpIHwgSEVSMiB8ICAgICAgfCAgICAgfCAgICAgIHwgICAgICAgfCAgICAgICAgfAp8IOW+t+absuWmpeePoOWNleaKlyB8IERhaWljaGkgU2Fua3lvIHwgSEVSMiB8ICAgICAgfCAgICAgfCAgICAgIHwgICAgICAgfCAgICAgICAgfAp8IOaBqee+juabsuWmpeePoOWNleaKlyB8IFJvY2hlIHwgSEVSMiB8ICAgICAgfCAgICAgfCAgICAgIHwgICAgICAgfCAgICAgICAgfAp8IHR1c2FtaXRhbWFiIHJhdnRhbnNpbmUgfCBJbW11bm9HZW4gfCBDRUEgfCAgICAgIHwgICAgIHwgICAgICB8ICAgICAgIHwgICAgICAgIHwKfCBEUDMwM2MgfCDnn7Poja/pm4blm6IgfCBIRVIyIHwgICAgICB8ICAgICB8ICAgICAgfCAgICAgICB8ICAgICAgICB8CnwgTENCMTQtMDExMCB8IOWkjeaYn+WMu+iNryB8IEhFUjIgfCAgICAgIHwgICAgIHwgICAgICB8ICAgICAgIHwgICAgICAgIHwKfCBNUkcwMDIgfCDnvo7pm4Xnj4IgfCBIRVIyIHwgICAgICB8ICAgICB8ICAgICAgfCAgICAgICB8ICAgICAgICB8CnwgTVJHMDAzIHwg576O6ZuF54+CIHwgRUdGUiB8ICAgICAgfCAgICAgfCAgICAgIHwgICAgICAgfCAgICAgICAgfAp8IGxhZGlyYXR1enVtYWIgdmVkb3RpbiB8IFNlYWdlbiB8IExJVi0xIHwgICAgICB8ICAgICB8ICAgICAgfCAgICAgICB8ICAgICAgICB8CnwgZW5mb3J0dW1hYiB2ZWRvdGluIHwgU2VhZ2VuIHwgbmVjdGluLTQgfCAgICAgIHwgICAgIHwgICAgICB8ICAgICAgIHwgICAgICAgIHwKfCBkYXRvcG90YW1hYiBkZXJ1eHRlY2FuIHwgRGFpaWNoaSBTYW5reW8gfCBUUk9QMiB8ICAgICAgfCAgICAgfCAgICAgIHwgICAgICAgfCAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yM5Lic5YyX6K+B5Yi4
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
所属报告:
荣昌生物-公司研究报告-新适应症持续拓展逐步向Biopharma迈进-230104(60页).pdf
打包全文图表
相关数据
使用维迪西妥单抗(RC48)2.0mg/kg治疗的患者周围
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
收藏
行业数据
2025-06-27
原图定位
查看详情
RC48vsDS8201治疗HER2-患者
5aW955qE44CCCgrku6XkuIvmmK/or6Xlm77ooajkuK3nmoTmlbDmja7ku6Xlj4rlr7nlupTnmoTooajmoLzlkozotYTmlpnmnaXmupDvvJoKCnwg5oyH5qCHICAgICAgIHwgUkM0OCB8IERTODIwMSB8CnwtLS0tLS0tLS0tLS18LS0tLS0tfC0tLS0tLS0tfAp8IGNPUlIgICAgICAgfCAzOS42JXwgMzcuMCUgIHwKfCBEQ1IgICAgICAgIHwgODkuNiV8IDg3LjAlICB8CnwgVFJBReKJpTMgICAgIHwgNDIuMCV8IDYxLjQlICB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jlhazlkYrvvIzlhazlj7jmi5vogqHkuabvvIzkuK3kv6Hlu7rmipU=
收藏
行业数据
2023-06-20
原图定位
查看详情
维迪西妥单抗RC48净现值测算(rNPV法)
fCDml7bpl7QgfCAyMDIyRSB8IDIwMjNFIHwgMjAyNEUgfCAyMDI1RSB8IDIwMjZFIHwgMjAyN0UgfCAyMDI4RSB8IDIwMjlFIHwgMjAzMEUgfCAyMDMxRSB8IDIwMzJFIHwKfC0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwKfCDkurrlj6PmlbDvvIjkuIfkurrvvIkgfCAxNDg0ODcgfCAxNDUyMTMgfCAxNDU1MjUgfCAxNDU3OTEgfCAxNDYwMDkgfCAxNDYxODAgfCAxNDYzMDUgfCAxNDYzODkgfCAxNDY0MzQgfCAxNDY0NDIgfCAxNDY0MTMgfAp8IOS5s+iFuueZjOWPkeeXheeOh++8iOavj+WNgeS4h+S6uu+8iSB8IDI3MCB8IDMwMC4wIHwgMzMwLjAgfCAzNjAuMCB8IDM5MC4wIHwgNDIwLjAgfCA0NTAuMCB8IDQ4MC4wIHwgNTEwLjAgfCA1NDAuMCB8IDU3MC4wIHwKfCDpgILlupTnl4fkurrmlbDvvIjkuIfkurrvvIkgfCAxMS43MyB8IDEzLjA3IHwgMTQuNDEgfCAxNS43NSB8IDE3LjA4IHwgMTguNDIgfCAxOS43NSB8IDIxLjA4IHwgMjIuNDAgfCAyMy43MiB8IDI1LjA0IHwKfCBSQzQ45rK755aXSEVSMumYs+aAp+S5s+iFuueZjOW5tOaAu+i0ueeUqO+8iOS6v+WFg++8iSB8IDAgfCAwIHwgMCB8IDEuNzAgfCAzLjYyIHwgNS43MyB8IDguMDMgfCAxMC41MCB8IDEwLjk0IHwgMTEuMzUgfCAxMS43NCB8Cnwg6IOD55mM5Y+R55Sf546H77yI5q+P5Y2B5LiH5Lq677yJIHwgNTUuMDAgfCA2OC4wMCB8IDgxLjAwIHwgOTQuMDAgfCAxMDcuMDAgfCAxMjAuMDAgfCAxMzMuMDAgfCAxNDYuMDAgfCAxNTkuMDAgfCAxNzIuMDAgfCAxODUuMDAgfAp8IOmAguW6lOeXh+S6uuaVsO+8iOS4h+S6uu+8iSB8IDQuNzggfCA1LjkyIHwgNy4wNyB8IDguMjIgfCA5LjM3IHwgMTAuNTIgfCAxMS42OCB8IDEyLjgyIHwgMTMuOTcgfCAxNS4xMSB8IDE2LjI1IHwKfCBSQzQ45rK755aXSEVSMumYs+aAp+iDg+eZjOW5tOaAu+i0ueeUqO+8iOS6v+WFg++8iSB8IDEuODIgfCA0LjUwIHwgOC4wNiB8IDEyLjUwIHwgMTMuOTYgfCAxNS4zNiB8IDE2LjcwIHwgMTcuOTggfCAxNy42MiB8IDE3LjI3IHwgMTYuOTIgfAp8IOWwv+i3r+S4iuearueZjOWPkeeUn+eOh+S4uu+8iOavj+WNgeS4h+S6uu+8iSB8IDUuNDAgfCA1LjY1IHwgNS45MCB8IDYuMTUgfCA2LjQwIHwgNi42NSB8IDYuOTAgfCA3LjE1IHwgNy40MCB8IDcuNjUgfCA3LjkwIHwKfCDpgILlupTnl4fkurrmlbDvvIjkuIfkurrvvIkgfCA0LjY5IHwgNC45MiB8IDUuMTUgfCA1LjM4IHwgNS42MSB8IDUuODMgfCA2LjA2IHwgNi4yOCB8IDYuNTAgfCA2LjcyIHwgNi45NCB8CnwgUkM0OOayu+eWl0hFUjLpmLPmgKflsL/ot6/kuIrnmq7nmYzlubTmgLvotLnnlKjvvIjkur/lhYPvvIkgfCA5LjI5IHwgMTEuNzAgfCAxMy42MCB8IDE3Ljc1IHwgMjAuMzEgfCAyMi4xOCB8IDIyLjU4IHwgMjIuOTQgfCAyMi40OCB8IDIyLjAzIHwgMjEuNTkgfAp8IOiDhumBk+eZjCvpu5HoibLntKDnmKQr5aaH56eR6IK/55ikK05TQ0xD5Y+R55Sf546H77yI5q+P5Y2B5LiH5Lq677yJIHwgOS4xMCB8IDEzLjEwIHwgMTcuMTAgfCAyMS4xMCB8IDI1LjEwIHwgMjkuMTAgfCAzMy4xMCB8IDM3LjEwIHwgNDEuMTAgfCA0NS4xMCB8IDQ5LjEwIHwKfCDpgILlupTnl4fkurrmlbDvvIjkuIfkurrvvIkgfCAxMy4xOCB8IDE5LjAyIHwgMjQuODggfCAzMC43NiB8IDM2LjY1IHwgNDIuNTQgfCA0OC40MyB8IDU0LjMxIHwgNjAuMTggfCA2Ni4wNSB8IDcxLjg5IHwKfCBSQzQ45rK755aX6IOG6YGT55mMK+m7keiJsue0oOeYpCvlpofnp5Hogr/nmKQrTlNDTEPmgLvotLnnlKjvvIjkur/lhYPvvIkgfCAwIHwgMCB8IDAgfCAwIHwgMCB8IDYuNTQgfCA3LjI5IHwgOC4wMiB8IDguNzAgfCA5LjM2IHwgOS45OSB8Cnwg5YeA5Yip5ram546w5YC877yI5Lq/5YWD77yJIHwgMi4yMiB8IDMuMjQgfCA0Ljk4IHwgNy4zMSB8IDYuMDggfCA2LjkyIHwgNy40OCB8IDguMjYgfCA4LjMzIHwgNy42NCB8IDYuOTkgfAp8IE5QVu+8iOS6v+WFgw==
收藏
行业数据
2023-01-10
原图定位
查看详情
RC48联合特瑞普利单抗对UC患者的靶病变相比基线的最佳变化
fCBIRVIyIEV4cHJlc3Npb24gfCBJSEMgMCB8IElIQyAxKyB8IElIQyAyKyB8IElIQyAzKyB8CnwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLXwKfCBQZXJjZW50IENoYW5nZSBmcm9tIEJhc2VsaW5lIHwgLTQwJSAgfCAtNjAlICAgfCAtODAlICAgfCAtMTAwJSAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45oub6IKh6K+05piO5Lmm77yM5Lic5YyX6K+B5Yi4
收藏
行业数据
2023-01-10
原图定位
查看详情
RC48维迪西妥单抗多维度布局临床管线(临床进展截止2022年12月)
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
收藏
行业数据
2023-01-10
原图定位
查看详情
RC48显示出具有临床意义的缓解效果及生存率
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
收藏
行业数据
2023-01-10
原图定位
查看详情
目前国内胃癌领域ADC在研管线较少,RC48管线领先优势明显
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
收藏
行业数据
2023-01-10
原图定位
查看详情
RC48和DS8201治疗HER2低表达乳腺癌临床数据对比
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
收藏
行业数据
2022-09-19
原图定位
查看详情
RC48对于HER2低表达乳腺癌患者的缓解情况
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
收藏
行业数据
2022-09-15
原图定位
查看详情
RC48后线乳腺癌适应症销售预测
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
收藏
行业数据
2022-09-15
原图定位
查看详情
RC48联合特瑞普利单抗对UC患者的靶病变相比基线的最佳变化
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
收藏
行业数据
2022-09-15
原图定位
查看详情
维迪西妥单抗(RC48)结构及机理
fCDnu7Tov6ropb/lpqXljZXmipfvvIhSQzQ477yJ57uT5p6E5Y+K5py655CGIHwgIHwKfCAtLS0gfCAtLS0gfAp8IE1DIHwgVmFsLUNpdC1QQUIgIHwKfCBNTUFFIHwgUEFCICB8Cnwg5oqX5L2TIHwg6L+e5o6l5a2QICB8CnwgTU1BRee7k+WQiOW+rueuoeibi+eZvSB8ICB8CnwgTU1BReWSjOW+rueuoeibi+eZveiBmuWQiCB8ICB8Cnwg57uG6IOe5YeL5LqhIHwgIHwKfCBSQzQ4LUFEQyB8ICB8CnwgUkM0OOe7k+WQiEhFUjLlj5fkvZMgfCAgfAp8IFJDNDgtSEVSMuWkjeWQiOeJqeiiq+WGheWQniB8ICB8Cnwg6L+e5o6l5a2Q5Zyo5rq26YW25L2T5Lit6KKr5Ymq5YiH5Y+KTU1BReiiq+mHiuaUviB8ICB8
收藏
行业数据
2022-06-15
原图定位
查看详情
图表22RC18第48周SRI-4应答率变化(FAS)
5aW955qE44CCCgp8IOWIhuexuyAgICAgICB8IOaVsOaNriAgIHwKfC0tLS0tLS0tLS0tLXwtLS0tLS0tLXwKfCAyNDBtZyBOPTYyIHwgNzUuOCUgIHwKfCAxNjBtZyBOPTYzIHwgNjguMyUgIHwKfCA4MG1nIE49NjIgIHwgNzEuMCUgIHwKfCDlronmhbDliYIgTj02MnwgMzMuOSUgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOaLm+iCoeS5pu+8jOWNjuWuieivgeWIuOeglOeptuaJgA==
收藏
行业数据
2022-06-08
原图定位
查看详情
图表21RC18主要终点SRI-4应答率第0-48周变化(PPS)
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
收藏
行业数据
2022-06-08
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
RC48 维迪西妥单抗的获批填补了患者二线及以上的治疗空白。根据 RC48-C009 研究,既往接受过化疗的 HER2 阳性晚期 UC 患者接受维迪西妥单抗治疗的 ORR 可达到 51.2%,疾病控制率(DCR)达到 90.7%,中位无进展生存期(mPFS)6.9 个月,中位总生存(OS)13.9 个月。其中有 22 名患者部分缓解(PR),17 名患者保持疾病稳定(SD)。对于有肝转移的患者,ORR 为 65%(13/20)。整体中位 PFS 为6.9 个月,中位 OS 为 13.9 个月,有若干患者出现超过 30 周的持续缓解和目前晚期UC 的二线标准治疗相比,维迪西妥单抗数据极具优势,因此成为 HER2 阳性晚期UC 患者的新型治疗选择。
行业数据
原图定位
当前图表所属:
荣昌生物-公司研究报告-新适应症持续拓展逐步向Biopharma迈进-230104(60页).pdf
维迪西妥单抗RC48净现值测算(rNPV法)
中国已上市尿路上皮癌(UC)适应症治疗药物临床数据比较
目前国内胃癌领域ADC在研管线较少,RC48管线领先优势明显
国内现存晚期胃癌后线诊疗方法ORR有限
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》